状星细胞A2A-D2受体-受体相互作用及其在神经精神疾病中的作用
Chiara Cervetto1, Guido Maura2, Diego Guidolin3
1Department of Pharmacy, Section of Pharmacology and Toxicology, University of Genova, Genova, Italy; Center for Promotion of 3Rs in Teaching and Research (Centro 3R), Pisa, Italy.
Neuropharmacology
|June 15, 2023
概括
星球细胞积极参与大脑的通信,影响突触传输. 新的研究表明,腺A2A和多巴胺D2受体在星球细胞上形成异构体,控制谷氨酸的释放并影响神经疾病.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 天星细胞被认为是突触传播的积极参与者.
- 中枢神经系统的沟通正在从神经中心转变为神经-天文中心的观点.
- 与G蛋白结合的受体可以形成异构体,改变信号识别和转导通路.
研究的目的:
- 审查在星球细胞上腺素A2A和多巴胺D2受体异构的证据.
- 讨论天体细胞A2A-D2异构体在控制谷氨酸释放中的作用.
- 探索这些异构体在条状谷氨基基酶传播和相关疾病中的相关性.
主要方法:
- 关于受体异构化的现有科学文献的综述.
- 对研究天体细胞信号传递和神经递质受体功能的研究分析.
- 对天体细胞中原生A2A-D2异构体形成的证据的检查.
主要成果:
- 有证据表明,本地腺A2A和多巴胺D2受体在星球细胞等离子体膜上异构.
- 星细胞A2A-D2异构体控制从条状星细胞过程中释放的谷氨酸.
- 这些异构体代表了调节条状质质转移的一种新机制.
结论:
- 氨酸A2A和多巴胺D2受体异构体存在于星球细胞内并发挥作用.
- 天体细胞异体体在调节谷氨酸性神经递质中起着重要作用.
- 天体细胞A2A-D2异构体的失调可能导致神经系统疾病,如帕金森病和精神分裂症.
相关概念视频
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
765
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
765
Neurochemical Transmission: Sites of Drug Action
2.5K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.5K
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
721
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
721


